Cargando…
Antiangiogenic Strategies in Epithelial Ovarian Cancer: Mechanism, Resistance, and Combination Therapy
Angiogenesis is one of the hallmarks of cancer and plays a crucial role in carcinogenesis and progression of epithelial ovarian cancer. Antiangiogenic agent is the first approved targeted agent in ovarian cancer. Anti-angiogenic agents mainly include agents target VEGF/VEGFR pathway, such as bevaciz...
Autores principales: | Jin, Chengwen, Yuan, Mingyuan, Bu, Hualei, Jin, Chengjuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9019437/ https://www.ncbi.nlm.nih.gov/pubmed/35466318 http://dx.doi.org/10.1155/2022/4880355 |
Ejemplares similares
-
Development and Validation of an Immune-Related Prognostic Signature in Cervical Cancer
por: Su, Rongjia, et al.
Publicado: (2022) -
Antiangiogenic therapies in ovarian cancer
por: Reinthaller, Alexander
Publicado: (2016) -
Coexistence of benign struma ovarii, pseudo-Meigs’ syndrome and elevated serum CA 125: Case report and review of the literature
por: JIN, CHENGJUAN, et al.
Publicado: (2015) -
Identification of hub genes in key hallmarks of ovarian cancer via bioinformatics analysis
por: Su, Rongjia, et al.
Publicado: (2021) -
Antiangiogenic drugs in ovarian cancer
por: Kumaran, G C, et al.
Publicado: (2009)